Estradiol (E2)

When high

When symptomatic (gyno, bloating, ED, mood, high BP):

First-line -- SERM (blocks at tissue, preserves systemic E2):

• Tamoxifen (Nolvadex) -- 10-20mg/day for gyno prevention
• Raloxifene -- 60mg/day; SERM with stronger evidence than tamoxifen for reversing established gynecomastia tissue when a palpable lump is already present (Lawrence et al. 2004); preferred when reversing existing gyno tissue rather than preventing new growth

Supplements (weak evidence, worth knowing the limits):

• DIM (diindolylmethane) -- 100-300mg/day, and the evidence does not support taking it for E2 control. It is sold as a natural aromatase inhibitor and it is not one. No human trial has ever shown DIM lowering total or free serum oestradiol in anyone. Its only measured endocrine effect is a shift in the ratio of oestrogen metabolites excreted in urine, and even that failed to reach significance in the larger of the two available trials (Nikitina et al., 2015, P=0.35). Both were in women being studied for breast cancer risk; there is no trial in men, let alone men on exogenous testosterone. In male rats at comparable doses it reduced sperm quality, and in vitro it acts as an androgen receptor antagonist, which is the opposite of the intended effect. If your E2 is genuinely high and symptomatic, use a real AI and monitor it

Second-line -- AI (lowers systemic E2, worsens lipids):

• Anastrozole -- 0.25-0.5mg EOD, lowest effective dose
• Exemestane -- 12.5mg EOD
• Letrozole -- 1.25-2.5mg/day as a short-term rescue dose only for an acute gyno flare-up; never as maintenance AI (crashes E2 catastrophically and devastates lipids and libido); physician-supervised

Injection strategy adjustments (often more effective than adding an AI):

• Split or increase injection frequency to EOD/E3D -- reduces the post-injection testosterone peak that drives aromatisation; often resolves symptoms without any AI
• Reduce aromatising compound dose -- single highest-leverage change; taper test/dbol/nandrolone before reaching for pharmacology
• Switch to a lower-aromatising base -- replace part of the testosterone dose with Primobolan or Masteron; both aromatise minimally and Masteron has mild anti-estrogenic activity at the AR level

Important: Never use prophylactic AI without symptoms. AIs worsen lipid profiles.

Which symptoms actually track high E2, and when an aromatase inhibitor is genuinely needed: How to recognize high estradiol on TRT.

Why DIM is sold for this job and cannot do it, with the trials that failed to replicate: the on-cycle support protocol.

When low

When low (rare on cycle; common during over-aggressive AI use or post-cycle):

• Stop or reduce aromatase inhibitors immediately if E2 is <70 pmol/L on TRT or you have crashed-E2 symptoms (joint pain, dry skin, low libido, depressed mood, suicidal ideation, poor lipids). Do not chase a "normal" number with more AI.
• Allow E2 to recover naturally; this can take 1-3 weeks once aromatase resumes activity.
• Increase aromatising base if running a low-aromatising stack (e.g., trenbolone-only or Primobolan-only): add a small testosterone dose (100-150mg/week) to restore normal E2 production.
• Reduce or remove anti-estrogens during PCT carefully; if using Tamoxifen/Clomid, monitor mood and lipids.
• Recheck E2 in 2-4 weeks before considering further intervention.

If you are running boldenone, the compound itself can suppress E2 without any AI involved: Why boldenone crashes your E2 and how to fix it.